Patent Assignment
Reel/Frame 018854/0467
Assignment of Assignor's Interest
Recorded: 2007-02-05
Pages: 10
Assignor
ALEXANDER STEINKASSERER, PH.D.
Executed: 2004-12-01
Assignee
ARGOS THERAPEUTICS, INC.
4233 TECHNOLOGY DRIVE, DURHAM, NORTH CAROLINA, 27704
Covered Properties
(3)
Soluble CD83 Proteins and Use Thereof for the Treatment or Prevention of a Disease or Medical Condition Caused by Dysfunction or Undesired Function of a Cellular Immune Repsonse Involving T Cells
Nucleic Acid or Recombination Expression Vector Encoding Soluble Forms of CD83, Host Cells Transformed/Transfected Therewith and Pharmaceutical Compositions Containing Same
Use of Soluble Forms of CD83 and Nucleic Acids Encoding Them for the Treatment or Prevention of Diseases
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 30, 2007
From: STEINKASSERER, ALEXANDER PROF. DR.; LECHMANN, MATTHIAS DR.; ZINSER, DIPL. ING. ELISABETH
To: STEINKASSERER, ALEXANDER, PROFESSOR DR.
Reel/Frame 018828/0532 →
Assignment of Assignor's Interest
Feb 5, 2007
From: STEINKASSERER, ALEXANDER; LECHMANN, MATTHIAS; ZINSER, ELISABETH
To: ALEXANDER STEINKASSERER
Reel/Frame 018853/0181 →
Assignment of Assignor's Interest
Mar 20, 2019
From: ARGOS THERAPEUTICS, INC.
To: COIMMUNE, INC.
Reel/Frame 048645/0673 →